MALLORY WITTIG: Open Payments
NPI 1114285517 · METROPOLIS, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$898 in 44 payments from 17 companies in 2025. Trend: 2023 $1,536 · 2024 $1,654 · 2025 $898
Food & beverage: $884Education: $14
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $228 |
| Novo Nordisk Inc | 5 | $101 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $98 |
| Amgen Inc. | 5 | $80 |
| PFIZER INC. | 3 | $54 |
| Novartis Pharmaceuticals Corporation | 3 | $49 |
| GlaxoSmithKline, LLC. | 3 | $47 |
| Medtronic, Inc. | 1 | $35 |
| Exact Sciences Corporation | 2 | $34 |
| Gilead Sciences, Inc. | 1 | $32 |
Products named: FARXIGA, Kerendia, BREZTRI, Ozempic, ELIQUIS, LEQVIO, TRELEGY ELLIPTA, Rybelsus.
Industry payments across IL — which companies pay providers there.
